BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17089694)

  • 1. Current practice in the operation and validation of aseptic blow-fill-seal processes.
    Ljungqvist B; Reinmüller B; Löfgren A; Dewhurst E
    PDA J Pharm Sci Technol; 2006; 60(4):254-8. PubMed ID: 17089694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aseptic processing contamination case studies and the pharmaceutical quality system.
    Friedman RL
    PDA J Pharm Sci Technol; 2005; 59(2):118-26. PubMed ID: 15971544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Media-fill simulation tests in manual and robotic aseptic preparation of injection solutions in syringes.
    Krämer I; Federici M; Kaiser V; Thiesen J
    J Oncol Pharm Pract; 2016 Apr; 22(2):195-204. PubMed ID: 25549919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, development and qualification of a microbiological challenge facility to assess the effectiveness of BFS aseptic processing.
    Leo F; Poisson P; Sinclair CS; Tallentire A
    PDA J Pharm Sci Technol; 2005; 59(1):33-48. PubMed ID: 15796134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some observations on airborne particles in the critical areas of a blow-fill-seal machine.
    Sundström S; Ljungqvist B; Reinmüller B
    PDA J Pharm Sci Technol; 2009; 63(1):71-80. PubMed ID: 19455943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenging our aseptic skills using more-rigorous media-fill tests.
    Kastango ES
    Am J Health Syst Pharm; 2012 Jul; 69(14):1197. PubMed ID: 22761072
    [No Abstract]   [Full Text] [Related]  

  • 7. Consideration of media fill tests for evaluation and control of aseptic processes: a statistical approach to quality criteria.
    Kawamura K; Abe H
    PDA J Pharm Sci Technol; 2002; 56(5):235-41. PubMed ID: 12404718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aseptic simulation test challenged with microorganisms for validation of pharmacy operators.
    Sigward E; Fourgeaud M; Vazquez R; Guerrault-Moro MN; Brossard D; Crauste-Manciet S
    Am J Health Syst Pharm; 2012 Jul; 69(14):1218-24. PubMed ID: 22761076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blow/fill/seal process.
    Sinclair CS; Tallentire A
    PDA J Pharm Sci Technol; 1996; 50(4):199-200. PubMed ID: 8810832
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA's aseptic processing: proposed regulation.
    Barr DB
    J Parenter Sci Technol; 1993; 47(2):57-9. PubMed ID: 8515345
    [No Abstract]   [Full Text] [Related]  

  • 11. Environmental microbial challenges to an aseptic Blow-Fill-Seal process--a practical study.
    Jones DJ; Topping P; Sharp J
    PDA J Pharm Sci Technol; 1995; 49(5):226-34. PubMed ID: 7489196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The media fill (simulation) test is the best method to evaluate aseptic processing.
    Kawamura K
    PDA J Pharm Sci Technol; 2002; 56(2):57-8. PubMed ID: 11977403
    [No Abstract]   [Full Text] [Related]  

  • 13. Choosing a Vial Processing Line for Aseptic Compounding: Part 1.
    Noorian S; Vahedi N
    Int J Pharm Compd; 2016; 20(4):283-292. PubMed ID: 28333673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proposal for a new categorization of aseptic processing facilities based on risk assessment scores.
    Katayama H; Toda A; Tokunaga Y; Katoh S
    PDA J Pharm Sci Technol; 2008; 62(4):235-43. PubMed ID: 19174952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Blow/Fill/Seal extrusion through processing polymer contaminated with bacterial spores and endotoxin.
    Leo F; Poisson P; Sinclair CS; Tallentire A
    PDA J Pharm Sci Technol; 2004; 58(3):147-58. PubMed ID: 15233254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiological performance of a robotic system for aseptic compounding of cytostatic drugs.
    Geersing TH; Franssen EJF; Pilesi F; Crul M
    Eur J Pharm Sci; 2019 Mar; 130():181-185. PubMed ID: 30710619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control aspects of aseptically produced products.
    Avallone HL
    J Parenter Sci Technol; 1985; 39(2):75-9. PubMed ID: 3989616
    [No Abstract]   [Full Text] [Related]  

  • 18. The potential impact of USP 797 and what the JCAAI is doing about it.
    Nathan R
    Allergy Asthma Proc; 2007; 28(2):236-7. PubMed ID: 17479611
    [No Abstract]   [Full Text] [Related]  

  • 19. Airborne contamination during blow-fill-seal pharmaceutical production.
    Whyte W; Matheis W; Dean-Netcher M; Edwards A
    PDA J Pharm Sci Technol; 1998; 52(3):89-99. PubMed ID: 9691671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Top ten hot topics in parenteral science and technology.
    Akers MJ; Nail SL; Saffell-Clemmer W
    PDA J Pharm Sci Technol; 2007; 61(5):337-61. PubMed ID: 18047174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.